The Cooper Companies, Inc. COO
55.38
0.00
0.00%
as of 25 Sep
- Market cap
- $10.5B
- P/E
- 18.9×
Follow COO
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
The Cooper Companies, Inc. (COO) EBITDA
The Cooper Companies, Inc.'s EBITDA for fiscal 2025 was $1.1B, unchanged from fiscal 2024. Over the twelve months to 31 July 2026 it was $928.2M. Over the past ten years it has ranged from $428.1M (fiscal 2015) to $1.1B (fiscal 2024); the current reading is higher than 91% of that period. The Cooper Companies, Inc. ranks 8th of 51 Medical Instruments & Supplies companies by EBITDA.
EBITDA, annual
Annual
| Period | EBITDA | Change |
|---|---|---|
| FY2025 | $1.1B | (1.90%) |
| FY2024 | $1.1B | 19.98% |
| FY2023 | $900.8M | 5.52% |
| FY2022 | $853.7M | 4.74% |
| FY2021 | $815.1M | 36.10% |
| FY2020 | $598.9M | (27.63%) |
| FY2019 | $827.5M | 22.01% |
| FY2018 | $678.2M | 9.83% |
| FY2017 | $617.5M | 18.20% |
| FY2016 | $522.4M | 22.03% |
Quarterly
| Period | EBITDA | Change |
|---|---|---|
| Jul 2026 | $316.7M | 391.77% |
| Apr 2026 | $64.4M | (79.11%) |
| Jan 2026 | $308.3M | 29.10% |
| Oct 2025 | $238.8M | (11.91%) |
| 43 more quarters | Free account |
Against its own ten years
Low $428.1M
High $1.1B
Ten-year median
$815.1M
Current reading's percentile
91
EBITDA against peers
| Company | EBITDA |
|---|---|
| SOLV Solventum Corporation compare | $2.6B |
| BAX Baxter International Inc. compare | $1.5B |
| COO The Cooper Companies, Inc. | $928.2M |
| ALGN Align Technology, Inc. compare | $802.0M |
| ATR AptarGroup, Inc. compare | $784.6M |
| BLCO Bausch + Lomb Corporation compare | $749.0M |
| STVN Stevanato Group S.p.A. compare | $341.3M |
| RGEN Repligen Corporation compare | $161.0M |
| AVTR Avantor, Inc. compare | $124.8M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on COO
- Revenue
- Net income
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement